MGNX today
$2.25-$0.06 (-2.80%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $3.67
Key levels
Resistance$2.85
Resistance$2.59
Support$1.93
Support$1.59
Latest news & SEC filings
NewsMacroGenics adds two physicians to its board of directors
SEC FilingMacrogenics Inc filed an insider trading report (Form 4)
SEC FilingMacrogenics Inc filed a report on a major company event (Form 8-K)
All MGNX news →About MacroGenics
MacroGenics is a clinical-stage biopharmaceutical company that develops antibody-based treatments for cancer. Its pipeline includes antibody-drug conjugates and multi-specific antibodies, with three FDA-approved products out-licensed or sold to partners. The company also runs a manufacturing facility in Maryland that provides contract development and manufacturing services to collaborators and other clients.
Based on the company's 10-K filed Mar 9, 2026.
Nasdaq · Healthcare
MACROGENICS INC (MGNX)
What Is the Price Target for MGNX?
SEPT Low Target
$6.00
SEPT Mid Target
$8.50
SEPT High Target
$11.00
Analyst Consensus
$8.50
Is MGNX a Buy or Sell Right Now?
Thesis
- •Revenue growing -0.3% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MGNX.
Start Free Trial →Is MGNX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$6.80
15
Moat Score
NONE
2/9
Piotroski Score
-5.9
Altman Z-Score
What Is Smart Money Doing with MGNX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Bonvini Ezio | officer | Buy | 8,000 | $21K | Oct 6, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MGNX Growth Story
Revenue YoY
-0.3%
3yr Revenue CAGR
-0.5%
EPS Growth YoY
-10.28%
FCF Growth YoY
-15.1%
Revenue Trend
ACCELERATING
Dark Pool Trades for MGNX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MGNX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:34:10 | $2.26 | 1,100 | $$2K | SELL |
| 17:31:04 | $2.26 | 1,998 | $$5K | SELL |
| 17:01:21 | $2.27 | 1,000 | $$2K | BUY |
| 17:00:56 | $2.27 | 1,200 | $$3K | BUY |
| 17:00:56 | $2.27 | 1,071 | $$2K | BUY |
5 dark pool trades shown · $$14K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for MACROGENICS INC (MGNX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MGNX — frequently asked questions
What is MGNX stock price today?
MACROGENICS INC (MGNX) is at $2.25, down 2.80% (-$0.06) at the Nov 12, 2026 close.
Why is MGNX stock moving today?
Latest MGNX news — Nov 4, 2026: MacroGenics adds two physicians to its board of directors · Nov 3, 2026: Macrogenics Inc filed an insider trading report (Form 4)
What is the MGNX price target?
The average analyst price target for MGNX is $8.50, ranging from $6 to $11, based on 2 analysts. Latest: B. Riley Securities maintains on Aug 17, 2026.
What do analysts rate MGNX?
Analyst ratings for MGNX: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did MGNX beat earnings?
MGNX last reported on Aug 13, 2026: EPS $0.31 vs -$0.08 expected — a beat of 497.9%.
Does MGNX pay a dividend?
MGNX does not currently pay a dividend.
What are MGNX support and resistance levels?
Support: $1.93, $1.59, $1.32. Resistance: $2.59, $2.85, $3.19.
What are insiders doing with MGNX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on MGNX?
Nov 4, 2026: MacroGenics adds two physicians to its board of directors · Nov 3, 2026: Macrogenics Inc filed an insider trading report (Form 4) · Nov 3, 2026: Macrogenics Inc filed a report on a major company event (Form 8-K)